Patents by Inventor Mikhail Binnewies

Mikhail Binnewies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220411496
    Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
    Type: Application
    Filed: April 5, 2022
    Publication date: December 29, 2022
    Applicant: The Regents of the University of California
    Inventors: Matthew Krummel, Miranda Broz, Denise Wolf, Joshua Pollack, Mikhail Binnewies
  • Patent number: 11325973
    Abstract: Provided herein are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein such as an antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: May 10, 2022
    Assignee: The Regents of the University of California
    Inventors: Matthew Krummel, Miranda Broz, Denise Wolf, Joshua Pollack, Mikhail Binnewies
  • Publication number: 20210317211
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: June 10, 2021
    Publication date: October 14, 2021
    Inventors: Michel Streuli, Leonard G. Presta, Venkataraman Sriram, Aritra Pal, Nadine Jahchan, Mikhail Binnewies, Joshua L. Pollack, Xiaoyan Du